ETUDE BIOLOGIQUE ET BIOCHIMIQUE SUR L'ACTION INHIBITRICE DE L'INTERFERON DANS LA REPONSE IMMUNE.FALCOFF E.1977; DGRST-7571098; FR.; DA. 1977; PP. 1-25; H.T. 2; BIBL. 2 P.; (RAPP. FINAL, ACTION CONCERTEE: IMMUNOL. TRANSPLANT. ORGANES)Report

GENERAL PROCEDURES FOR PURIFICATION OF MOUSE IMMUNE INTERFERON = PROCEDES GENERAUX DE PURIFICATION DE L'INTERFERON IMMUN DE SOURISWIETZERBIN J; FALCOFF E.1981; METHODS ENZYMOL.; ISSN 0076-6879; USA; DA. 1981; VOL. 78; PP. 552-563; BIBL. 18 REF.Article

STUDIES ON BRUCELLA INTERFERON: CHROMATOGRAPHIC BEHAVIOUR AND PURIFICATIONBOUSQUET UCLA C; WIETZERBIN J; FALCOFF E et al.1980; ARCH. VIROL.; AUT; DA. 1980; VOL. 63; NO 1; PP. 57-68; BIBL. 40 REF.Article

DUAL ACTION OF DOUBLE-STRANDED RNA IN INHIBITING PROTEIN SYNTHESIS IN EXTRACTS OF INTERFERON-TREATED MOUSE L CELLS. TRANSLATION IS IMPAIRED AT THE LEVEL OF INITIATION AND BY MRNA DEGRADATION.LEWIS JA; FALCOFF E; FALCOFF R et al.1978; EUROP. J. BIOCHEM.; GERM.; DA. 1978; VOL. 86; NO 2; PP. 497-509; BIBL. 40 REF.Article

AN IMPROVED METHODOLOGY FOR PREPARATION OF VIRUS-INDUCED DOUBLE STRANDED RNAMECHALI M; PEREZ BERCOFF R; CARRARA G et al.1973; BIOCHIMIE; FR.; DA. 1973; VOL. 55; NO 3; PP. 361-363; BIBL. 16REF.Serial Issue

PRODUCTION OF ANTIBODIES AGAINST MOUSE IMMUNE T (TYPE II) INTERFERON AND THEIR NEUTRALIZINS PROPERTIESSTEFANOS S; CATINOT L; WIETZERBIN J et al.1980; J. GEN. VIROL.; ISSN 0022-1317; GBR; DA. 1980; VOL. 50; NO 1; PP. 225-229; BIBL. 21 REF.Article

ENHANCEMENT OF MOUSE NATURAL KILLER CELL ACTIVITY BY TYPE II INTERFERONSENIK A; STEFANOS S; KOLB JP et al.1980; ANN. IMMUNOL.; FRA; DA. 1980; VOL. 131; NO 3; PP. 349-361; ABS. FRE; BIBL. 26 REF.Article

MOUSE FIBROBLAST (TYPE I) AND IMMUNE (TYPE II) INTERFERONS: PRONOUNCED DIFFERENCES IN AFFINITY FOR GANGLIOSIDES AND IN ANTIVIRAL AND ANTIGROWTH EFFECTS ON MOUSE LEUKEMIA L-1210R CELLSANKEL H; CHITRA KRISHNAMURTI; BESANCON F et al.1980; PROC. NATION. ACAD. SCI. U.S.A.; USA; DA. 1980; VOL. 77; NO 5; PP. 2528-2532; BIBL. 29 REF.Article

LOCATION OF ENHANCED RIBONUCLEASE ACTIVITY AND OF A PHOSPHOPROTEIN KINASE IN INTERFERON-TREATED MENGOVIRUS-INFECTED CELLSAUJEAN O; SANCEAU J; FALCOFF E et al.1979; VIROLOGY; USA; DA. 1979; VOL. 92; NO 2; PP. 583-586; BIBL. 25 REF.Article

COMPARISON OF EFFECTS OF LEUKOCYTE AND FIBROBLAST INTERFERON ON IMMUNOLOGICAL PARAMETERS IN CANCER PATIENTSLUCERO MA; MAGDELENAT H; FRIDMAN WH et al.1982; EUR. J. CANCER CLIN. ONCOL.; ISSN 0277-5379; GBR; DA. 1982; VOL. 18; NO 3; PP. 243-251; BIBL. 32 REF.Article

Effects of human recombinant interferons-α₂, -β and -γ on growth- and survival of human cancer nodules maintained in continuous organotypic cultureBEAUPAIN, R; BILLARD, C; FALCOFF, E et al.European journal of cancer & clinical oncology. 1986, Vol 22, Num 2, pp 141-149, issn 0277-5379Article

INVOLVEMENT OF A RADIORESISTANT CELL IN THE PRODUCTION OF CIRCULATING INTERFERON INDUCED BY NOCARDIA FRACTIONS IN MICEBAROT CIORBARU R; CATINOT L; WIETZERBIN J et al.1981; J. RETICULOENDOTHEL. SOC.; ISSN 0033-6890; USA; DA. 1981; VOL. 30; NO 4; PP. 247-257; BIBL. 41 REF.Article

EFFECT OF VARIOUS INTERFERONS ON THE SPONTANEOUS CYTOTOXICITY EXERTED BY LYMPHOCYTES FROM NORMAL AND TUMOR-BEARING PATIENTSLUCERO MA; FRIDMAN WH; PROVOST MA et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 1; PP. 294-299; BIBL. 29 REF.Article

INDUCTION OF INTERFERON SYNTHESIS IN MICE BY FRACTIONS FROM NOCARDIA.BAROT CIORBARV R; WIETZERBIN J; PETIT JF et al.1978; INFECT. AND IMMUN.; U.S.A.; DA. 1978; VOL. 19; NO 2; PP. 353-356; BIBL. 15 REF.Article

PRESENCE OF A POLYNUCLEOTIDE BINDING SITE ON MURINE IMMUNE INTERFERON (T-TYPE)WIETZERBIN J; STEFANOS S; LUCERO M et al.1978; BIOCHEM. BIOPHYS. RES. COMMUNIC.; USA; DA. 1978; VOL. 85; NO 1; PP. 480-489; BIBL. 14 REF.Article

INFECTIVITY OF MENGOVIRUS REPLICATIVE FORM. RELATIONSHIP TO CELLULAR TRANSCRIPTION = L'INFECTIVITE DE LA FORME REPLICATIVE DU MENGOVIRUS. RAPPORTS AVEC LA TRANSCRIPTION CELLULAIREPEREZ BERCOFF R; CIOE L; MEO P et al.1974; J. GEN. VIROL.; G.B.; DA. 1974; VOL. 25; NO 1; PP. 53-62; BIBL. 1 P. 1/2Article

Human platelets possess receptors for a lymphokine: demonstration of high specific receptors for HuIFN-γMOLINAS, F. C; WIETZERBIN, J; FALCOFF, E et al.The Journal of immunology (1950). 1987, Vol 138, Num 3, pp 802-806, issn 0022-1767Article

¹²⁵I-labelled human interferons alpha, beta and gamma: comparative receptor-binding dataMERLIN, G; FALCOFF, E; AGUET, M et al.Journal of general virology. 1985, Vol 66, Num 5, pp 1149-1152, issn 0022-1317Article

SYNERGISTIC ACTIVITIES OF TYPE I (ALPHA ,BETA ) AND TYPE II (GAMMA ) MURINE INTERFERONSZERIAL A; HOVANESSIAN AG; STEFANOS S et al.1982; ANTIVIR. RES.; ISSN 0166-3542; NLD; DA. 1982; VOL. 2; NO 4; PP. 227-239; BIBL. 29 REF.Article

PHYSICO-CHEMICAL CHARACTERIZATION AND PARTIAL PURIFICATION OF MOUSE IMMUNE INTERFERONWIETZERBIN J; STEFANOS S; LUCERO M et al.1979; J. GEN. VIROL.; GBR; DA. 1979; VOL. 44; NO 3; PP. 773-781; BIBL. 28 REF.Article

THE INHIBITION OF TRANSLATION OF SYNTHETIC POLYRIBONUCLEOTIDES AND MENGO RNA IN EXTRACTS FROM INTERFERON-TREATED 2 CELLS AND ITS REVERSION BY YEAST TRNASFALCOFF R; LEBLEU B; SANCEAU J et al.1976; BIOCHEM. BIOPHYS. RES. COMMUNIC.; U.S.A.; DA. 1976; VOL. 68; NO 4; PP. 1323-1331; BIBL. 17 REF.Article

STUDY OF TWO DOUBLE-STRANDED RIBONUCLEIC ACIDS OF VIRAL ORIGIN: INTERFERON INDUCING AND ANTIVIRAL ACTIVITIESFAYET MT; BRANCHE R; FALCOFF E et al.1972; PROGR. IMMUNOBIOL. STANDARD.; SWITZ.; DA. 1972; VOL. 5; PP. 267-273; BIBL. 13REF.; (PROC. 12TH INT. CONGR. MICROBIOL. STAND.; ANNECY; 1971)Conference Paper

Mise en évidence de la 2-5A synthétase dans les cellules mononuclées circulantes chez l'homme après administration orale d'un inducteur d'interféron présent dans une fraction issue d'Escherichia coli et Klebsiella pneumoniae = Identification of the 2'-5'- synthetase in mononuclear cells circulating in man after oral administration of an interferon inductor found in a fraction coming from Escherichia coli and Klebsiella pneumoniaeMERLIN, G; VANDERHOVEN, C; PAGE, Y.-M et al.Comptes rendus de l'Académie des sciences. Série 3, Sciences de la vie. 1985, Vol 300, Num 17, pp 619-622, issn 0764-4469Article

Lepromatous leprosy treated with recombinant interfern gamma : cutaneous histologic changesROTTASSO, O; BESUSCHIO, S; MERLIN, V et al.International journal of dermatology. 1992, Vol 31, Num 11, pp 813-817, issn 0011-9059Article

Similar biological effects of different low doses of interferon alpha in cancer patientsBILLARD, C; DIEZ, R. A; FERBUS, D et al.British journal of cancer. 1987, Vol 55, Num 6, pp 677-679, issn 0007-0920Article